Merkel cell polyomavirus (MCV) is the causative agent for the majority of Merkel cell
carcinoma (MCC) cases. Polyomavirus-associated MCC (MCCP) is characterized by the …

In this review, we summarize the immunology of nonmelanoma skin cancers (NMSCs) and
the clinical data with immunotherapy in this heterogeneous group of cancers that include …

Nonmelanoma skin cancer (NMSC) is the most frequently diagnosed malignancy in
humans, representing a broad range of cutaneous tumors. Keratinocyte carcinomas …

Merkel cell carcinoma (MCC), a rare but aggressive skin cancer, remains a challenge in the
era of precision medicine. Immune checkpoint inhibitors (ICIs), the only approved therapy for …

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer that frequently
carries an integrated Merkel cell polyomavirus (MCPyV) genome and expresses viral …

Immuno-oncology is a rapidly evolving field with growing relevance in the treatment of
numerous malignancies. The prior study of immunotherapy in dermatologic oncology has …

Background Merkel cell carcinoma (MCC) is an aggressive neuroendocrine (NE) skin
cancer caused by severe UV-induced mutations or expression of Merkel cell polyomavirus …

Simple Summary Merkel cell carcinoma (MCC) is a rare and highly aggressive type of skin
neuroendocrine cancer that frequently recurs and metastasizes within a relatively short …

Despite the success of immune checkpoint blockade as a strategy for activating an antitumor
immune response and promoting cancer regression, only a subset of patients have durable …

Merkel cell carcinoma (MCC) is a rare, highly aggressive, neuroendocrine cutaneous tumor.
The incidence of MCC is growing worldwide, and the disease-related mortality is about three …